SCHEMBL23660967

SCHEMBL23660967

FC(F)(F)C(=C(C(F)(F)F)C(F)(F)F)N1CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
MLYCD O95822 2/20 0.36
CA1 P00915 4/20 0.36
CA2 P00918 4/20 0.36
CA12 O43570 3/20 0.36
CA9 Q16790 3/20 0.36
F2 P00734 1/20 0.36
HPGD P15428 5/20 0.35
MEN1 O00255 1/20 0.35
TSHR P16473 1/20 0.35
KMT2A Q03164 1/20 0.35
MGLL Q99685 2/20 0.35
PIN1 Q13526 1/20 0.35
PHGDH O43175 1/20 0.35
ALDH2 P05091 1/20 0.35
FBP1 P09467 1/20 0.35
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23660963 0.97 MLYCD (0.38) ALDH1A1MLYCDCA1CA2CA12
SCHEMBL23660968 0.85 MLYCD (0.33) ALDH1A1MLYCDCA1CA2CA12
SCHEMBL23661365 0.85 MLYCD (0.33) ALDH1A1MLYCDCA1CA2CA12
SCHEMBL18942813 0.84 ALDH1A1 (0.35) ALDH1A1MLYCDCA1CA2CA12
SCHEMBL17453100 0.84 ALDH1A1 (0.35) ALDH1A1MLYCDCA1CA2CA12
SCHEMBL23661367 0.82 MLYCD (0.33) MLYCD
SCHEMBL17453108 0.81 MLYCD (0.35) ALDH1A1MLYCDCA1CA2CA12
SCHEMBL18121411 0.74 MLYCD (0.34) ALDH1A1MLYCDHPGDTSHRMAPT
SCHEMBL23660970 0.74 CA12 (0.41) ALDH1A1MLYCDCA1CA2CA12
SCHEMBL23661364 0.70 NAMPT (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210221776-A1 PERFLUOROAMINOOLEFINS AND METHODS OF MAKING AND USING THE SAME 3M INNOVATIVE PROPERTIES COMPANY 2021-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210221776-A1 PERFLUOROAMINOOLEFINS AND METHODS OF MAKING AND USING THE SAME FGB, RFTN1, AFF1 ALDH1A1 4051/4885MLYCD 3104/4885CA1 2040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.